SG biotech firm Lion TCR bags $40m funding from Chinese investors

SG biotech firm Lion TCR bags $40m funding from Chinese investors

A worker pulls a cart under the Liede Bridge over the Pearl River in Guangzhou, China, on Wednesday, Nov. 1, 2017. Photographer: Qilai Shen/Bloomberg

27 June, 2023

Edited by: Joymitra Rai

biotech Guangzhou Industrial Investment and Capital Operation Holding Group Lion TCR

Printed by Unregistered user on Sat, 26 Jul 2025 14:36:34 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Data Vantage: Legit Group, Komunal, Prixa and Lion TCR welcome new funding

Venture Capital

Singapore: Clinical stage biotech Lion TCR bags $20m from Yashang Capital, others

Read more from Greater China

Hong Kong IPO boom triggers price war among banks

Chinese e-commerce giants defend ‘instant retail’ strategy despite state pressure